نوع مقاله : اصیل پژوهشی
نویسندگان
1 دانشیار گروه زنان و مامایی، واحد توسعه و تحقیقات بالینی بیمارستان بعثت، دانشکده پزشکی، دانشگاه علوم پزشکی کردستان، سنندج، ایران.
2 پزشک عمومی، واحد توسعه و تحقیقات بالینی بیمارستان بعثت، دانشکده پزشکی، دانشگاه علوم پزشکی کردستان، سنندج، ایران.
3 دانشیار اپیدمیولوژی، مرکز تحقیقات کبد و گوارش، پژوهشکده توسعه سلامت، دانشگاه علوم پزشکی کردستان، سنندج، ایران.
چکیده
کلیدواژهها
موضوعات
عنوان مقاله [English]
نویسندگان [English]
Introduction: Recurrent abortion is one of the problems of reproductive medicine and its prevalence is higher in women with polycystic ovarian syndrome (PCOS). Although anticoagulants and aspirin are commonly used for treatment, there is not enough evidence to support the effectiveness of the treatment. This study was conducted with aim to evaluate the effect of aspirin and enoxaparin on the prevention of recurrent abortion in patients with PCOS.
Methods: This retrospective cohort study was conducted in 2017-2018 on 40 women aged 20-40 years with polycystic ovary syndrome (PCOS) and a history of two or more recurrent abortion who achieved pregnancy following ovulation induction therapy for infertility. After ovulation induction and confirming an intrauterine pregnancy, the patients were divided into two groups: Enoxaparin and control. Both groups were received aspirin from the third month of gestation. Then, pregnancy outcomes were compared between the two groups and were followed-up. Data analysis was performed using SPSS (version 17) and Mann-Whitney, Chi-square, and Fisher’s exact tests. P<0.05 was considered statistically significant.
Results: There was no statistically significant difference between the two groups in terms of age, number of pregnancies, delivery, and miscarriage. In the enoxaparin and aspirin group, 16 individuals (80%) had full-term delivery compared to 12 individuals (60%) in the aspirin group, although the difference was not statistically significant (P=0.3).
Conclusion: In women with polycystic ovary syndrome, the group receiving enoxaparin and aspirin experienced approximately a 20% reduction in recurrent abortion. Although the results were not statistically significant due to the small sample size, they have clinical value and warrant further investigation.
کلیدواژهها [English]